CDMO business mainly refers to providing customers with process research and development, process optimization,quality and stability research, customized production and other services of pharmaceutical intermediates and APIs.

From the perspective of drug life cycle, the company mainly serves the clinical development stage of innovative drugs of multinational pharmaceutical companies and the commercial sales stage after the drug market, and also partly serves theresearch and development and marketing stage of generic drugs.